Patents by Inventor Leping AN

Leping AN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8921369
    Abstract: Provided herein are compounds, pharmaceutical compositions and combination therapies for inhibition of hepatitis C.
    Type: Grant
    Filed: December 2, 2009
    Date of Patent: December 30, 2014
    Assignee: Presidio Pharmaceuticals, Inc.
    Inventors: Min Zhong, Leping Li
  • Patent number: 8910223
    Abstract: A higher network sends a base stream of a data stream to a first network node, and sends an enhancement stream of the data stream to a second network node. The first network node transmits the base stream over a multicast channel and the second network node transmits the enhanced stream in synchronism with the transmitted base stream over a unicast channel. Various options are detailed for how this synchronism is achieved, and the second network node need only transmit the higher bit-rate enhancement stream on user request or if network conditions permit. A user equipment receives the base and enhancement streams, combines them, and displays the combined stream to a user at a graphical display interface. Various apparatus, methods, and computer programs are detailed for various nodes and the user equipment.
    Type: Grant
    Filed: October 24, 2007
    Date of Patent: December 9, 2014
    Assignee: Nokia Coporation
    Inventors: Leping Huang, Kodo Shu
  • Patent number: 8891487
    Abstract: In one non-limiting, exemplary embodiment, a method includes: receiving radio resource control signaling with a user equipment, wherein the radio resource control signaling is indicative of at least one frequency sub-band to be measured by the user equipment for a particular cell in a manner transparent to at least one of an interference control scheme and a handover scheme implemented for the cell; performing at least one measurement of the at least one frequency sub-band; and reporting information descriptive of the at least one measurement.
    Type: Grant
    Filed: September 11, 2012
    Date of Patent: November 18, 2014
    Assignee: Nokia Corporation
    Inventors: Leping Huang, Kodo Shu, Hongyuan Chen, Sari Kaarina Nielsen, Lars Dalsgaard, Jarkko T. Koskela
  • Patent number: 8877707
    Abstract: Provided herein are compounds, pharmaceutical compositions and combination therapies for inhibition of hepatitis C.
    Type: Grant
    Filed: May 23, 2011
    Date of Patent: November 4, 2014
    Assignee: Presidio Pharmaceuticals, Inc.
    Inventors: Min Zhong, Leping Li
  • Patent number: 8865756
    Abstract: Provided herein are compounds, pharmaceutical compositions and combination therapies for inhibition of hepatitis C.
    Type: Grant
    Filed: December 2, 2009
    Date of Patent: October 21, 2014
    Assignee: Presidio Pharmaceuticals, Inc.
    Inventors: Leping Li, Min Zhong
  • Publication number: 20140302836
    Abstract: An apparatus for automatic switching functions of components thereof, includes a housing having an upper end and a lower end, a first microphone fixed on the upper end of the housing, a second microphone fixed on the lower end of the housing, an orientation detecting unit having an acceleration sensor for detecting the current orientation of the apparatus for generating an orientation signal, a switching control unit for switching the functions of the microphones when the orientation signal indicates the apparatus is reversed.
    Type: Application
    Filed: April 2, 2014
    Publication date: October 9, 2014
    Applicant: AAC ACOUSTIC TECHNOLOGIES (SHENZHEN) CO., LTD.
    Inventors: Qi TANG, Leping DONG
  • Patent number: 8850703
    Abstract: With a method for finish-machining the blade tips of rotor wheels made in BLISK design, the rotor wheel or multi-stage compressor rotor (1), is machined—blade by blade and stage by stage—at the blade tips (2) by a conical cutter (5) whose cutting edge (6) is oriented tangentially to the outside surface of the rotor wheel/compressor rotor and routed on the blade tip essentially along the centerline thereof, with the cutting force being introduced perpendicular to the tool axis and in the stiffest direction of the blade (3), i.e. the centerline (11) of the blade cross-section and the perpendicular axis extending from the centerline. The cutting action and the force introduction of the conical cutter at the blade tip allow production of blade tips with a geometrically precisely defined edge without setting the respective blades into vibration.
    Type: Grant
    Filed: January 12, 2010
    Date of Patent: October 7, 2014
    Assignee: Rolls-Royce Deutschland Ltd & Co KG
    Inventors: Leping Zhu, Gregor Riedel
  • Publication number: 20140286899
    Abstract: A class of compounds that inhibit Hepatitis C Virus (HCV) is disclosed, along with compositions containing the compound, and methods of using the composition for treating individuals infected with HCV.
    Type: Application
    Filed: November 18, 2013
    Publication date: September 25, 2014
    Applicant: Presidio Pharmaceuticals, Inc.
    Inventors: Min Zhong, Leping Li
  • Patent number: 8822520
    Abstract: Provided herein are compounds, pharmaceutical compositions and combination therapies for treatment of hepatitis C.
    Type: Grant
    Filed: September 21, 2011
    Date of Patent: September 2, 2014
    Assignee: Presidio Pharmaceuticals, Inc.
    Inventors: Min Zhong, Leping Li
  • Patent number: 8812046
    Abstract: In accordance with aspects of the present invention, a method, apparatus and system are provided for self-optimization of interference coordination in communication systems. In one embodiment, the apparatus includes a measurement and reporting subsystem configured to perform measurements regarding a status of the apparatus and to provide a reliability report to a base station as a function thereof. The apparatus is configured to notify a strongest interferer about the status via the reliability report. In another embodiment, the apparatus includes a measurement report handler configured to process a reliability report received from a user equipment and an interference coordination subsystem configured to adjust interference coordination parameters based on the reliability report received from the user equipment.
    Type: Grant
    Filed: August 30, 2012
    Date of Patent: August 19, 2014
    Assignee: Nokia Corporation
    Inventors: Leping Huang, Kodu Shu
  • Patent number: 8805369
    Abstract: Methods, apparatus and computer program products perform signal quality measurements for signals from a plurality of cells served by an apparatus, and transmit indications of the signal quality measurements to the apparatus. The signal quality measurements may include CQI measurements. Transmitting may include transmitting indications of the signal quality measurements to a source cell of the apparatus. Other methods, apparatus and computer program products perform signal quality measurements for signals from a plurality of cells served by an apparatus, determine, using at least the signal quality measurements, a frequency band to be used by each of the plurality of cells to transmit a command, and transmit an indication of the frequency band to the apparatus. Variants may include receiving over the frequency band the command from each of the plurality of cells.
    Type: Grant
    Filed: March 12, 2008
    Date of Patent: August 12, 2014
    Assignee: Nokia Corporation
    Inventors: Leping Huang, Kodo Shu, Tero Henttonen
  • Patent number: 8785468
    Abstract: Provided herein are compounds of formula I: wherein A, B, X, R1, R2 and subscript n are as defined in the following disclosure. Compositions comprising the compounds are also provided, as well as methods for their use, for example, in treatment of type 2 diabetes and type 2 diabetes-related conditions.
    Type: Grant
    Filed: February 12, 2010
    Date of Patent: July 22, 2014
    Assignee: Amgen Inc.
    Inventors: Xiaohui Du, Zice Fu, Jonathan B. Houze, XianYun Jiao, Yong-Jae Kim, Leping Li, Jinqian Liu, Mike Elias Lizarzaburu, Julio C. Medina, Wang Shen, Simon Turcotte, Ming Yu
  • Patent number: 8767351
    Abstract: The presently disclosed technology describes systems and methods for attaining a ball bond using less than 1 thousandth of an inch diameter gold wire using ultrasonic bonding energy and without heating an underlying bonding pad. The ball bond allows the use of particularly small bonding pads that are particularly close to adjacent microelectronic structures that limit the use of other bonding techniques that have shallow take-off angles.
    Type: Grant
    Filed: January 31, 2013
    Date of Patent: July 1, 2014
    Assignee: Seagate Technology LLC
    Inventors: Leping Li, Saravuth Keo, Kara L. Maytag, Pramit P. Parikh, Jeff R. O'Konski, Mark A. Herendeen, Joel W. Hoehn, Roger L. Hipwell, Joe J. Schobel, John L. Ibele, Ralph Marquart, Edward Knutson
  • Publication number: 20140154105
    Abstract: Embodiments of the present invention provides an oil balancing apparatus, applied to at least three compressors connected in parallel. The oil balancing apparatus includes a first oil balancing pipe and a second oil balancing pipe. The first oil balancing pipe connects oil sumps of all the compressors, and the second oil balancing pipe only connects oil sumps of oil-rich compressors but not an oil sump of an oil-starved compressor.
    Type: Application
    Filed: November 22, 2013
    Publication date: June 5, 2014
    Applicant: Danfoss (Tianjin) Ltd.
    Inventors: Hongling Xu, Leping Zhang, Kongkham Lovan
  • Patent number: 8709999
    Abstract: Provided herein are compounds, pharmaceutical compositions and combination therapies for treatment of hepatitis C.
    Type: Grant
    Filed: March 26, 2010
    Date of Patent: April 29, 2014
    Assignee: Presidio Pharmaceuticals, Inc.
    Inventors: Min Zhong, Leping Li
  • Patent number: 8618151
    Abstract: Provided herein are compounds, pharmaceutical compositions, and combination therapies for inhibition of hepatitis C.
    Type: Grant
    Filed: December 4, 2012
    Date of Patent: December 31, 2013
    Assignee: Presidio Pharmaceuticals, Inc.
    Inventors: Leping Li, Min Zhong
  • Patent number: 8614207
    Abstract: A class of compounds that inhibit Hepatitis C Virus (HCV) is disclosed, along with compositions containing the compound, and methods of using the composition for treating individuals infected with HCV.
    Type: Grant
    Filed: July 9, 2012
    Date of Patent: December 24, 2013
    Assignee: Presidio Pharmaceuticals, Inc.
    Inventors: Min Zhong, Leping Li
  • Publication number: 20130316180
    Abstract: A method for forming an electrical-conductor-free vapor barrier suitable for protecting long-term implanted electronic systems is disclosed. The method comprises forming a nascent layer of a partially cured layer and repeatedly compressing the layer via a roller-based process. Once the layer has been suitably compressed, the layer is fully cured. In some embodiments, a multi-layer protective layer is formed by repeating the roller-based formation process for each of a plurality of layers. In some embodiments, a multi-layer protective layer comprising layers of different materials is formed.
    Type: Application
    Filed: May 7, 2013
    Publication date: November 28, 2013
    Applicant: Case Western Reserve University
    Inventors: Wen H. Ko, Shem Lachman, Christian A. Zorman, Leping Bu
  • Publication number: 20130310427
    Abstract: Antiviral compounds may be used to inhibit or reduce the activity of Hepatitis C virus (HCV), particularly HCV's NS5A protein. In these contexts, inhibition and reduction of activity of the NS5A protein refers to a lower level of the measured activity relative to a control experiment in which the cells or the subjects are not treated with the test compound. The inhibition or reduction in the measured activity is at least a 10% reduction or inhibition. The compounds and their isomeric forms and pharmaceutically acceptable salts thereof are useful in treating and preventing HCV infection alone or when used in combination with other compounds targeting viral or cellular elements or functions involved in the HCV lifecycle.
    Type: Application
    Filed: June 9, 2011
    Publication date: November 21, 2013
    Applicant: PRESIDIO PHARMACEUTICALS, INC.
    Inventors: Leping Li, Min Zhong
  • Publication number: 20130302282
    Abstract: A class of compounds that inhibit Hepatitis C Virus (HCV) is disclosed, along with compositions containing the compound, and methods of using the composition for treating individuals infected with HCV.
    Type: Application
    Filed: October 21, 2011
    Publication date: November 14, 2013
    Applicant: Presidio Pharmaceuticals, Inc.
    Inventors: Min Zhong, Leping Li